Today, November 11, a World Health Organization (WHO) advisory group will review the coronavirus situation and decide whether the COVID-19 booster doses should be administered globally.
The demand for booster doses has grown as the number of COVID-19 patients has increased. With such a large population vaccinated, it will be simple to administer booster doses.
The European Medicines Agency approved booster dosages of BioNTech/Pfizer and Moderna for immunocompromised patients last month. The WHO announced that it is analysing the issue and will make a decision on the need and timing of the booster dose based on that evaluation.
For the unversed, booster shots are given to individuals who are completely vaccinated to improve immunity and give more clinical protection. The main objective is to retain the vaccine’s effectiveness in the body of the individual.
Covaxin manufacturer, Krishna Ella also mentioned that its nasal vaccine has cleared the Phase-2 trial and is likely to be available soon. He also said that the government is looking to add it to the Cowin platform to begin clinical trials.
